The preclinical discovery and development of brexpiprazole for the treatment of major depressive disorder-Reference-Cited by-同舟云学术

The preclinical discovery and development of brexpiprazole for the treatment of major depressive disorder

Published:2017-07-18 Issue:10 Volume:12 Page:1067-1081
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Aftab Awais¹^ORCID,Gao Keming²

Affiliation:

1. Department of Psychiatry, Residency Training Program, University Hospitals Cleveland Medical Center/Case Western Reserve University School of Medicine, Cleveland, OH, USA

2. Mood and Anxiety Clinic in the Mood Disorders Program, Department of Psychiatry, University Hospitals Cleveland Medical Center/Case Western Reserve University School of Medicine, Cleveland, OH, USA

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2017.1354849

Reference64 articles.

1. Development of Lifetime Comorbidity in the World Health Organization World Mental Health Surveys

2. Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

3. The Epidemiology of Major Depressive Disorder

4. Reducing the Societal Burden of Depression

5. The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in representative small-molecule DRD2 inhibitors: Synthetic Routes and clinical applications;European Journal of Medicinal Chemistry;2024-11

2. Efficacy and Safety of Antidiabetic Agents for Major Depressive Disorder and Bipolar Depression: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials;Journal of Clinical Medicine;2024-02-19

3. Comparative efficacy and safety of 4 atypical antipsychotics augmentation treatment for major depressive disorder in adults: A systematic review and network meta-analysis;Medicine;2023-09-22

4. Quality of life among Iranian major depressive disorder patients: a qualitative study;Middle East Current Psychiatry;2023-03-06

5. Brexpiprazole—Pharmacologic Properties and Use in Schizophrenia and Mood Disorders;Brain Sciences;2023-02-25